Kinloch Capital’s Eli Lilly LLY Stock Holding History

Kinloch Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Sell	239 -6	-2%	-$6.08K	0.09%	75
2025 Q4	$263K	Sell	245 -544	-69%	-$520K	0.11%	66
2025 Q3	$602K	Hold	789	–	–	0.26%	53
2025 Q2	$615K	Hold	789	–	–	0.29%	52
2025 Q1	$651K	Sell	789 -114	-13%	-$94.9K	0.31%	55
2024 Q4	$697K	Sell	903 -6	-0.7%	-$4.97K	0.35%	53
2024 Q3	$805K	Hold	909	–	–	0.39%	56
2024 Q2	$823K	Hold	909	–	–	0.43%	53
2024 Q1	$707K	Buy	909 +339	+59%	+$241K	0.36%	52
2023 Q4	$332K	Sell	570 -147	-21%	-$85.8K	0.21%	55
2023 Q3	$385K	Buy	717 +147	+26%	+$75.7K	0.24%	53
2023 Q2	$267K	Sell	570 -146	-20%	-$61.2K	0.16%	60
2023 Q1	$246K	Hold	716	–	–	0.14%	61
2022 Q4	$262K	Sell	716 -11	-2%	-$3.9K	0.15%	56
2022 Q3	$235K	Buy	+727	New	+$230K	0.16%	61
2021 Q1	–	Sell	-228	Closed	-$38K	–	136
2020 Q4	$38K	Buy	+228	New	+$34K	0.03%	120

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kinloch Capital's LLY Position: Q1 2026 in Review

Kinloch Capital reduced its Eli Lilly (LLY) stake by 2.4% in Q1 2026, selling an estimated $6.08K and leaving 239 shares worth $220K. The position accounts for 0.09% of the portfolio, ranked #75.

Kinloch Capital first reported a position in LLY in Q4 2020 and has held it in 16 quarters since. The position peaked at $823K in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Kinloch Capital held 239 shares of Eli Lilly worth $220K as of Q1 2026.
Kinloch Capital sold 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
Eli Lilly made up 0.09% of Kinloch Capital's portfolio in Q1 2026, its #75 holding.
Kinloch Capital first reported a position in Eli Lilly in Q4 2020 and has held it in 16 quarters since.
Kinloch Capital's Eli Lilly position peaked at $823K in Q2 2024.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kinloch Capital's 13F filing for Q1 2026, filed 15 May 2026.